Abstract:An androgen receptor (AR) is an intensively studied treatment target for castration-resistant prostate cancer that is irresponsive to conventional antiandrogen therapeutics. Binding function 3 (BF3) inhibitors with alternative modes of action have emerged as a promising approach to overcoming antiandrogen resistance. However, how these BF3 inhibitors modulate AR function remains elusive, hindering the development of BF3-targeting agents. Here, we performed an integrated computational study to interrogate the binding mechanism of several known BF3 inhibitors with ARs. Our results show that the inhibitory effect of the BF3 antagonists arises from their allosteric modulation of the activation function (AF2) site, which alters the dynamic coupling between the BF3 and AF2 sites as well as the AF2-coactivator (SRC2-3) interaction. Moreover, the per-residue binding energy analyses reveal the "anchor" role of the linker connecting the phenyl ring and benzimidazole/indole in these BF3 inhibitors. Furthermore, the allosteric driver-interacting residues are found to include both "positive", e.g., Phe673 and Asn833, and "negative" ones, e.g., Phe826, and the differential interactions with these residues provide an explanation why stronger binding does not necessarily result in higher inhibitory activities. Finally, our allosteric communication pathway analyses delineate how the allosteric signals triggered by BF3 binding are propagated to the AF2 pocket through multiple short- and/or long-ranged transmission pathways. Collectively, our combined computational study provides a comprehensive structural mechanism underlying how the selected set of BF3 inhibitors modulate AR function, which will help guide future development of BF3 antagonists.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jcim.1c00124?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jcim.1c00124</a>.Structure and biological activity of BF3 antagonists with the benzimidazole scaffold; binding energies including contributions from enthalpy (ΔEele + ΔEvdW + ΔGGB + ΔGSA) and entropy (−TΔS) changes; per-residue binding energies and corresponding components of key residues; binding free energies and the corresponding energy terms of SRC23 peptide with AF2 in BF3 bound and unbound ARs; key residues involved in the interaction between ARs and SRC23; predicted allosteric BF3 → AF2 pathways in androgen-bound ARs by the Monte Carlo (MC) path generation approach; RMSDs of backbone atoms as a function of simulation time for AR/TES/SRC23; structural comparison of the AF2 surfaces; differences in the SRC binding interaction energy contributions of individual AR residues; community structures of residue contact networks; and propensities of residues being sensors/effectors mapped onto ribbon diagrams of AR and the corresponding PRS maps of the BF3 antagonistic AR/TES in complex with BF3 antagonists (<a class="ext-link" href="/doi/suppl/10.1021/acs.jcim.1c00124/suppl_file/ci1c00124_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Structural mechanism underlying variations in DNA binding by the androgen receptor

Communication between the ligand-binding pocket (LBP) and the activation function-2 (AF2) domain of androgen receptor revealed by molecular dynamics simulations.

Communication between the Ligand-Binding Pocket and the Activation Function-2 Domain of Androgen Receptor Revealed by Molecular Dynamics Simulations

Molecular Dynamics Simulations Revealed the Regulation of Ligands to the Interactions between Androgen Receptor and Its Coactivator

Dynamic Communication Between Androgen and Coactivator: Mutually Induced Conformational Perturbations in Androgen Receptor Ligand-Binding Domain

Genomic Androgen Receptor-Occupied Regions with Different Functions, Defined by Histone Acetylation, Coregulators and Transcriptional Capacity.

Structural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes

Agonist and antagonist switch DNA motifs recognized by human androgen receptor in prostate cancer.

Structural Diversity of Ligand-Binding Androgen Receptors Revealed by Microsecond Long Molecular Dynamics Simulations and Enhanced Sampling

Mechanism Underlying the Retarded Nuclear Translocation of Androgen Receptor Splice Variants

Androgen Receptor Corepressors: an Overview

Molecular Dynamics Simulations of a Chimeric Androgen Receptor Protein (SPARKI) Confirm the Importance of the Dimerization Domain on DNA Binding Specificity

Computational Analysis of Androgen Receptor (AR) Variants to Decipher the Relationship Between Protein Stability and Related-Diseases

The RNA secondary structure of androgen receptor-FL and V7 transcripts reveals novel regulatory regions

Isolation and Characterization of Androgen Receptor Mutant, AR(M749L), with Hypersensitivity to 17-Β Estradiol Treatment

Computational Analysis of Residue-Specific Binding Free Energies of Androgen Receptor to Ligands

Cell- and Gene-Specific Regulation of Primary Target Genes by the Androgen Receptor

Conformational dynamics of androgen receptors bound to agonists and antagonists

Molecular Mechanism of Bisphenol A on Androgen Receptor Antagonism.

Formation Of The Androgen Receptor Transcription Complex

Mechanistic Insights into the Allosteric Inhibition of Androgen Receptors by Binding Function 3 Antagonists from an Integrated Molecular Modeling Study